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Abstract
Clinical biochemistry has long been utilized in
human and veterinary medicine as a vital diagnos-
tic tool, but despite occasional studies showing its
usefulness in monitoring health status in Atlantic
salmon (Salmo salar L.), it has not yet been widely
utilized within the aquaculture industry. This is
due, in part, to a lack of an agreed protocol for
collection and processing of blood prior to analy-
sis. Moreover, while the analytical phase of clinical
biochemistry is well controlled, there is a growing
understanding that technical pre-analytical vari-
ables can influence analyte concentrations or activ-
ities. In addition, post-analytical interpretation of
treatment effects is variable in the literature, thus
making the true effect of sample treatment hard
to evaluate. Therefore, a number of pre-analytical
treatments have been investigated to examine their
effect on analyte concentrations and activities. In
addition, reference ranges for salmon plasma bio-
chemical analytes have been established to inform
veterinary practitioners and the aquaculture indus-
try of the importance of clinical biochemistry in
health and disease monitoring. Furthermore, a
standardized protocol for blood collection has
been proposed.
Keywords: clinical biochemistry, diagnostics, pre-
analytical, reference range, salmon, Biochemistry,
Non-destructive, Health monitoring, Pre-analytical
effects.
Introduction
Atlantic salmon are susceptible to a number of
diseases of known and unknown aetiology. These
diseases include various fungal, viral, bacterial and
parasitic pathogens which significantly reduce pro-
ductivity, sustainability and profitability of the
industry. While mortality and morbidity resulting
from infection and disease is highly variable and
dependent on a number of factors (Yousaf et al.
2013), it represents a sustainability problem for
the industry (Kibenge et al. 2012). However, it is
well established that disease impacts can be
reduced significantly through regular health moni-
toring of stocks (Raja & Jithendran 2015), with
implementation of treatments, and disease man-
agement strategies.
The tools for diagnosing infection and disease
in finfish aquaculture have grown significantly in
recent years (Adams & Thompson 2012). The use
of established diagnostic tools such as aetiological
agent isolation, PCR and serology has dramatically
increased. This is in part because the salmon
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aquaculture industry is moving away from reliance
on behavioural signs of disease to a more proac-
tive approach. However, it is widely established
that aetiological agents can be present for a period
of time before clinical signs are observed (Kristof-
fersen et al. 2009; Jansen et al. 2010). In terms of
disease management strategies, this is problematic
as the onset of a disease outbreak cannot be deter-
mined using current widely used non-destructive
tests. Therefore, there is a heavy reliance on
histopathology to identify the clinical manifesta-
tions of disease in salmon production. However,
histopathology is a laborious and time-consuming
process, which takes a high level of skill for proper
assessment. In addition, direct costs are increased
by the effect of fish being removed from the pop-
ulation for tissue sampling and therefore not
going to harvest. In addition, due to the sequen-
tial pathology of many diseases, such as pancreas
disease (PD), all disease indicators may not be vis-
ible at the same time point (McLoughlin et al.
2002). Repeat sampling may be required over a
period of time, adding to cost, and there is a dis-
tinct fish welfare issue associated with such reli-
ance on destructive sampling. Thus, there is
significant demand within the industry for non-
destructive means of health assessment capable of
diagnosing clinical disease while also allowing for
investigation of higher sample numbers.
Clinical biochemistry is the analysis of concen-
trations of numerous proteins, metabolites,
enzymes and electrolytes in bodily fluids, most
commonly blood-derived serum or plasma, for
non-destructive diagnosis and monitoring of dis-
ease. While such an approach is well established
in humans and in domestic, laboratory and live-
stock species (Braun et al. 2015), very little work
has investigated its usefulness in salmon aquacul-
ture. Despite this, studies in salmon have found
creatine kinase (CK) to increase in serum activity
during PD (Ferguson, Rice & Lynas 1986; Rod-
ger et al. 1991), and lactate dehydrogenase
(LDH) and CK to significantly increase due to
inflammation and necrosis during heart and
skeletal muscle inflammation (Yousaf & Powell
2012). However, the impact of these findings has
been restricted by limited understanding of the
decision point when results of these enzyme tests
become clinically significant. The CK values in
these studies were highly variable, and reference
ranges, which are imperative for effective identifi-
cation of disease problems, have not been
established. This variability may be due in part
to numerous pre-analytical biological factors,
which in human studies have been shown to
account for the majority of laboratory errors
influencing clinical decisions (Braun et al. 2015).
In addition, there have, to date, been no attempts
to establish standardized sampling protocols for
collection of serum or plasma from captive sal-
mon. Furthermore, the effect of technical pre-
analytical factors such as sampling technique and
specimen management has not been studied in
salmon. Such work is pivotal to the implementa-
tion of clinical biochemistry to the salmon aqua-
culture industry in order to prevent incorrect
classification of health status, to provide reliable
estimates of disease prevalence and crucially to
ensure that laboratory results are reliable.
Therefore, this study aimed to investigate technical
pre-analytical effects on clinical biochemical analysis to
assess how treatment of blood samples from salmon
can influence measurement of their biochemistry pro-
files. In total, 22 analytes were assayed in multiple
samples in distinct investigations covering the effects of
sample type (serum or plasma), the time before separa-
tion from blood cells, storage conditions and freeze–
thaw cycles. In addition, the study also aimed to estab-
lish the degree of individual variation within popula-
tions and if pre-analytical treatments could cause false
diagnosis of disease. Moreover, a standardized method-
ology of sampling and specimen care is proposed that
is in line with established protocols for use in other
livestock production sectors but not, so far, in aquacul-
ture (Humann-Ziehank & Ganter 2012).
Material and methods
General methods
This study focussed on establishing technical
pre-analytical effects on clinical biochemistry
parameters. Each investigation has different sample
handling procedures prior to clinical biochemical
analysis. Fish were sampled during a routine health
monitoring programme (Fish Vet Group, Inver-
ness, UK) from two separate production sites in the
west of Scotland with no reported disease problems.
Residual blood was used for analysis. The popula-
tions at these sites were both of mixed sex but var-
ied in age with one containing fish around
18 months of age and the other containing fish
around 24 months of age. Average water tempera-
ture and salinity from the sites on the day of
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sampling were 11.7 °C and 30.5 ppm, respectively.
Individuals with an average weight of 3.5 kg were
attracted through hand feeding and then taken out
of the population using a scoop net and placed in a
water bath containing a low dosage of tricaine
mesylate (PHARMAQ, Hampshire, UK) to cause
sedation. Blood was then sampled from the caudal
vein using blood collection tubes (non-vacuum
sealed) and aliquoted into 1.3-ml capacity tubes as
specified in each investigation. Fish were then
returned to their original pen.
Time from collection to separation of serum or
plasma was standardized at 3 h (apart from inves-
tigation 2 where time to separation was the vari-
able being studied). Separation was performed by
centrifugation at 10 000 rcf for 3 min. For each
investigation, paired samples were used with blood
from the same fish being subjected to both treat-
ment methods.
For each investigation, clinical biochemistry was
performed by the Veterinary Diagnostic Service of
the University of Glasgow, School of Veterinary
Medicine. Concentrations or activities of albumin,
alkaline phosphatase (ALP), alanine aminotrans-
ferase (ALT), amylase, aspartate aminotransferase
(AST), calcium, chloride, cholesterol, CK, crea-
tinine, gamma glutamyl transferase (GGT), globu-
lin, glucose, LDH, lipase, magnesium, phosphate,
potassium, sodium, total protein and albumin–
globulin and sodium–potassium were assayed
using Beckman Coulter assay kits (California,
USA) following manufacturer instructions on an
Olympus AU640 biochemical analyser (Beckmann
Coulter, CA, USA).
Investigation 1: effect of sample type
Blood from 40 salmon was split into plain collect-
ing tubes and lithium heparin tubes for the collec-
tion of sera and plasma, respectively, from each
individual fish. Samples were stored on wet ice
during transport to the laboratory. On arrival,
they were separated by centrifugation to serum or
plasma 3 h post-blood collection and stored at
4 °C, until clinical biochemistry was performed
24 h post-separation of serum/plasma. This is rep-
resented as a schematic in Fig. 1.
Investigation 2: effect of time to centrifugation
and glucose stabilization
Individual blood samples collected from 40 fish
were split into two lithium heparin blood tubes
with one from each fish separated and plasma
aspirated 3 h post-collection and stored at 4 °C
along with the unseparated tubes (see Fig. 2).
Separated plasma was subjected to clinical bio-
chemistry analysis 24 h post-separation. The
remaining tubes from each fish were centrifuged
and plasma collected at 27 h post-blood collec-
tion. These plasma samples were stored at 4 °C
for a further 24 h and then analysed.
In addition, an aliquot of blood from all fish in
this investigation was placed in fluoride oxalate
tubes (recommended for glucose analysis) which
were separated 3 h post-blood collection, held at
4 °C, with glucose concentration determined 24 h
post-separation. These values were compared to
glucose concentrations obtained from plasma from
lithium heparin tubes which were treated in the
same manner (Figs 3 & 4).
Investigation 3 effect of post-separation storage
Blood samples from 20 fish were aliquoted into
two lithium heparin tubes which were centrifuged
3 h post-blood collection. Plasma was then stored
at either 4 °C or at room temperature (RT) for
48 h before biochemical analysis. Blood samples
from a further 20 salmon were split and separated
Figure 1 Schematic diagram of investigation 1 which investigated clinical biochemistry parameters in serum and plasma.
3
Journal of Fish Diseases 2016 M Braceland et al. Clinical biochemistry of Atlantic salmon
 2016
The Authors Journal of
Fish Diseases Published
by John Wiley & Sons
Ltd.
in the same manner but were held either at 4 °C
or RT for 72 h prior to clinical biochemistry
assays being performed.
Investigation 4: effect of freeze–thaw cycles
Blood was collected from 20 fish and split into
two lithium heparin tubes with plasma separated
3 h post-collection. Half of the samples were
stored at 4 °C and the other half subjected to two
freeze–thaw cycles before clinical biochemistry was
performed. Similarly, blood from twenty further
fish was sampled and plasma split into two treat-
ment groups that were either stored at 4 °C, or
subjected to four freeze–thaw cycles.
Statistical analyses
To analyse pre-analytical treatment effects on clini-
cal biochemistry parameters, results were compared
between treatments in three ways to establish not
only statistical significant differences but also in
relation to clinical decision-making. Paired results
were analysed first by Wilcoxon signed-rank test
(WSRT) and then by paired t-test and unpaired t-
test (GraphPad version 6, San Diego CA, USA).
Reference intervals for biochemical analytes in
salmon plasma
Reference ranges were established for the biochemi-
cal analytes of salmon plasma samples (n = 120)
which had a normal (Gaussian) distribution by cal-
culation of the values at plus and minus 2 standard
deviations (SD) from the mean of the analyte val-
ues. When data was not normally distributed,
which was the case for CK and LDH, the 2.5th and
97.5th percentiles were used as the reference range
to include 95% of the sample results. The samples
were collected and processed using the standardized
protocol as described in the Results section of this
study. The reference intervals were used to deter-
mine whether change in an analyte caused by the
pre-analytical treatments under investigation was
sufficient to cause the analyte levels to be outside
the reference interval limits and potentially lead to
a false-positive result for the analyte.
Results
Investigation 1: effect of tube type
Comparison of analytes in serum and plasma
from the same salmon showed that the differences
Figure 3 Schematic of investigation 3 where the effect of storage temperature for prolonged periods was studied.
Figure 2 Schematic of investigation 2 which investigated the
effect of time between blood collection and separation of
plasma on biochemical parameters.
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in the majority of clinical biochemistry analytes in
plasma or serum were not significant. However,
there were significant differences in phosphate,
sodium and potassium concentrations between
plasma and serum on the basis of the unpaired t-
tests (as well as paired t-test and WSRT). Chlo-
ride and glucose levels were significant at the level
of paired t-test and WRST and albumin, ALP,
calcium and total protein on the basis of WSRT
exclusively. Table 1 shows the mean values of
these analytes. In addition, results of statistical
analysis are shown with p values from WSRT,
paired and unpaired t-tests. Salmon sera and
plasma had undetectable activities of GGT and
lipase.
Investigation 2: effect of time of separation and
use of fluoride collecting tubes for glucose
analysis
Extending the time of sample separation from 3 h
to 27 h post-blood collection caused a significant
reduction in ALT, chloride and glucose by all
tests of statistical significance used in the investi-
gation. In contrast, calcium, magnesium, phos-
phate and potassium significantly increased in
value. Smaller treatment effects were also observed
on ALP, AST, cholesterol and CK with these only
being found to be significantly different by
WSRT analysis but not t-tests due to population
variability (Table 2). There was no significant
difference in glucose concentration when using
lithium heparin or fluoride blood collecting tubes
(Table 3).
Investigation 3: effect of storage temperature
and time
Storage of samples for 48 (Table 4) h at room
temperature significantly reduced the activities of
ALP, ALT, AST and CK, and the concentration
of calcium, whereas concentrations of glucose, cre-
atinine, magnesium, phosphate and total protein
increased significantly by both paired t-test and
WSRT. These differences were generally small but
increased further after 72 h at RT (Table 5) with
ALP, ALT, AST and CK activities and calcium
concentration all being at lower activity/concentra-
tion in samples stored at room temperature and
with sodium lower only in the WSRT statistical
test. Only creatinine and phosphate were at signif-
icantly higher concentrations in samples stored at
room temperature for 72 h.
Investigation 4: effect of freeze–thaw cycles
Freezing and thawing samples was found to have
significant effects on albumin, globulin, ALP,
amylase, AST, calcium, chloride, cholesterol, crea-
tinine, phosphate, potassium, sodium and total
protein. In most cases, differences between control
and those freeze–thawed increased between 2x
Figure 4 Schematic of investigation 4. Clinical biochemistries were analysed from samples after storage at 4 °C for 24 h or after 2x
or 4x freeze–thaw cycles.
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(Table 6) and 4 9 cycles (Table 7). Moreover,
while 2x freeze–thaw cycles did not cause a signifi-
cant change in ALT by 4x freeze–thaw cycles, its
activity dropped significantly. In addition, most
differences between control and 2x freeze–thaw
cycles, while being significantly different by
WSRT and paired t-test, were not different by the
unpaired t-test. This indicated that any effect of a
2x freeze–thaw cycle would not significantly alter
interpretation of results from two independent
Table 1 Mean analyte values from both plasma (n = 40) and sera (n = 40) in addition to P values from statistical analyses by Wil-
coxon signed-rank test (WSRT), paired t-test and unpaired t-test with significant results (P = <0.05) are indicated in bold; ‘*’ indi-
cates that statistical analysis was not carried out due to insufficient paired sample numbers; ‘–’ indicates that statistical analysis was
not carried out as the analyte was undetectable in all samples
Analyte Plasma (SE) Sera (SE)
WSRT Paired t-test Unpaired t-test
P Value P Value P Value
Albumin (g/L) 14.08 (0.31) 13.35 (0.64) 0.03846 0.2952 0.3555
Albumin–Globulin (Ratio) 0.54 (0.01) 0.52 (0.02) 0.28014 0.5277 0.5151
ALP (U/L) 660 (28.72) 665 (32.3) 0.03318 0.5832 0.9281
ALT (U/L) 23.35 (2.59) 23.25 (2.96) 0.67448 0.8981 0.9833
Amylase (U/L) 957 (62) 980 (53.9) 0.08364 0.6487 0.7843
AST (U/L) 1435 (194.62) 1399 (243.31) 0.0784 0.9273 0.7469
Calcium (mmol/L) 3.15 (0.029) 3.0 (0.083) 0.0009 0.1059 0.1525
Chloride (mmol/L) 140.54 (+0.049) 142.3 (0.91) 0.02088 0.0124 0.1004
Cholesterol (mmol/L) 6.97 (0.18) 6.97 (0.19) 0.5485 0.9861 0.9977
Creatine Kinase (U/L) 5022 (1093.9) 5036 (823.65) * * *
Creatinine (umol/L) 22.57 (0.0801) 21.96 (0.96) 0.39532 0.3521 0.6834
GGT (U/L) 0 0 – – –
Globulin (g/L) 26.14 (0.51) 26.18 (0.74) 0.08544 0.9614 0.9686
Glucose (mmol/L) 4.51 (0.14) 4.18 (0.28) 0.00148 0.0001 0.1428
LDH (U/L) 1457 (671) 1293 (198.32) 0.08914 0.4636 0.5364
Lipase (U/L) 0 0 – – –
Magnesium (mmol/L) 1.62 (0.086) 1.29 (0.18) 0.32218 0.1969 0.1251
Phosphate (mmol/L) 7.01 (0.32) 8.47 (0.39) 0.00038 0.0001 0.0161
Potassium (mmol/L) 0.81 (0.06) 0.97 (0.025) 0.00278 0.0001 0.0002
Sodium (mmol/L) 170 (0.43) 173 (0.79) 0.00142 0.0012 0.0044
Sodium–Potassium (Ratio) 215 (5.64) 181 (4.97) 0.00386 0.0018 0.0002
Total Protein (g/L) 40.67 (0.67) 39.25 (1.5) 0.04444 0.1054 0.2493
Table 2 Mean analyte values from plasma when separated from cells either 3 (n = 40) or 27 (n = 40) h post-blood collection
Analyte 3 h (SE) 27 h (SE)
WSRT Paired t-test Unpaired t-test
P value P value P value
Albumin (g/L) 16.17 (0.16) 16.42 (0.18) 0.13362 0.095 0.3253
Albumin–Globulin (Ratio) 0.508 (0.004) 0.5055 (0.004) 0.76418 0.7989 0.6564
ALP (U/L) 614 (23.85) 633 (23.68) 0.00174 0.4409 0.5737
ALT (U/L) 18 (1.09) 11 (0.62) 0 0.0001 0.0001
Amylase (U/L) 1059 (49.06) 1113 (49.32) 0.07346 0.9796 0.4537
AST (U/L) 760 (76.62) 705 (65.59) 0.0027 0.6653 0.5852
Calcium (mmol/L) 3.28 (0.03) 3.40 (0.03) 0.00022 0.0001 0.0085
Chloride (mmol/L) 133 (0.47) 131 (0.61) 0.00262 0.0017 0.025
Cholesterol (mmol/L) 10.70 (0.24) 10.93 (0.22) 0.00174 0.5163 0.5071
Creatine Kinase (U/L) 9025 (968.46) 10803 (1018.8) 0.02642 0.2619 0.2183
Creatinine (umol/L) 32 (1.76) 30 (1.58) 0.17068 0.6823 0.5175
GGT (U/L) 0 0 – – –
Globulin (g/L) 31 (0.37) 32 (0.39) 0.00906 0.0062 0.198
Glucose (mmol/L) 5.51 (0.12) 2.94 (0.14) 0 0.0001 0.0001
LDH (U/L) 2233 (396.54) 1990 (300.55) 0.09894 0.2385 0.6207
Lipase (U/L) 0 0 – – –
Magnesium (mmol/L) 1.53 (0.06) 2.19 (0.06) 0 0.0001 0.0001
Phosphate (mmol/L) 5.8 (0.26) 7.9 (0.41) 0.0003 0.0003 0.0001
Potassium (mmol/L) 0.889 (0.02) 0.983 (0.03) 0.02202 0.0272 0.0163
Sodium (mmol/L) 166 (0.64) 167 (0.61) 0.93624 0.8905 0.8149
Sodium–Potassium (Ratio) 189 (3.18) 175 (5.2) 0.0455 0.0649 0.0445
Total Protein (g/L) 48 (0.49) 49 (0.55) 0.00528 0.0072 0.2059
Results of Wilcoxon signed-rank test (WSRT), paired t-test and unpaired t-test statistical analyses with significant differences (P = <0.05) indicated in
bold; ‘–’ indicates that statistical analysis was not carried out as the analyte was undetectable in all samples.
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studies or be clinically significant. However, after
4x cycles of freeze–thaw, more analytes were sig-
nificantly different by unpaired t-tests due to
increasing differential when compared to control
samples.
Reference intervals for clinical biochemistry
analytes
Reference intervals (Table 8) for 22 biochemical
analytes in salmon plasma were established using
120 samples which had been collected by the
optimized protocol outlined below.
Protocol for sample collection and pre-
analytical handling
From the results of this investigation, a sampling
and processing protocol for salmon blood samples
prior to biochemical analysis is proposed:
1 Collect blood from the caudal vein using a
non-vacuum-sealed blood collection tube and
immediately transfer into 1.3-mL capacity
lithium heparin tube.
2 Centrifuge at 10 000 g for 3 min to separate
plasma from the blood cells and transfer this
plasma to a labelled storage tube and put on
wet ice at 4 °C during transfer.
3 Analyse plasma biochemistry at 24 h post-
sampling.
4 In laboratory store at 4 °C before analysis.
5 After analysis, samples can be stored at 20 °C
or 80 °C for any further work or retesting.
Discussion
This study has shown that pre-analytical treatment
of salmon plasma or serum can cause significant
variability in clinical biochemistry analytes. The
three types of statistical analysis used in this study
Table 3 Mean glucose concentrations when using lithium heparin (lith = hep) (n = 40) or fluoride-coated blood collecting tubes
(n = 40) and P values of Wilcoxon signed-rank test (WSRT), and paired and unpaired t-tests
Analyte
Tube Type
Fluoride (SE)
WSRT Paired t-test Unpaired t-test
Lithium Heparin (SE) P Value P Value P Value
Glucose (mmol/l) 5.51 (0.12) 5.72 (0.14) 0.11876 0.094 0.248
Table 4 Effect of storage of plasma at 4 °C (n = 20) or room temperature (RT) (n = 20) for 48 h
48 h
4 °C (SE) RT (SE)
WSRT Paired t-test Unpaired t-test
Analyte P Value P Value P Value
Albumin (g/L) 15.35 (0.264) 15.6 (0.266) * 0.0563 0.5087
Albumin–Globulin (Ratio) 0.495 (0.007) 0.497 (0.005) * 0.6557 0.7775
ALP (U/L) 629 (33.3) 621 (32.99) 0.00854 0.0095 0.8529
ALT (U/L) 9.4 (0.822) 6 (0.497) 0.00014 0.0001 0.0011
Amylase (U/L) 1033 (61) 1038 (61.8) 0.17068 0.1114 0.9553
AST (U/L) 724.6 (107.8) 501.1 (68.9) 0.00008 0.0001 0.0876
Calcium (mmol/L) 3.32 (0.03) 3.28 (0.034) 0.00132 0.0006 0.339
Chloride (mmol/L) 133.19 (0.49) 132.3 (0.509) 0.07672 0.0533 0.2159
Cholesterol (mmol/L) 10.91 (0.289) 10.93 (0.292) 0.4413 0.5612 0.9586
Creatine Kinase (U/L) 9183 (1530) 7704 (1277) 0.00008 0.0001 0.4627
Creatinine (umol/L) 29.4 (1.98) 31.45 (2.06) 0.00062 0.0001 0.4777
GGT (U/L) 0 0 – – –
Globulin (g/L) 31.1 (0.542) 31.4 (0.596) 0.09296 0.0553 0.7117
Glucose (mmol/L) 5.15 (0.155) 5.23 (0.156) 0.02382 0.0095 0.7176
LDH (U/L) 1116 (214) 1077 (188.7) 0.82588 0.4782 0.892
Lipase (U/L) 0 0 – – –
Magnesium (mmol/L) 1.82 (0.027) 1.87 (0.026) 0.0012 0.0005 0.2108
Phosphate (mmol/L) 7.34 (0.168) 8.59 (0.257) 0.00008 0.0001 0.0003
Potassium (mmol/L) 0.82 (0.016) 0.855 (0.017) 0.11642 0.0593 0.1368
Sodium (mmol/L) 165 (0.356) 166 (0.498) 0.08012 0.0578 0.0945
Sodium–Potassium (Ratio) 203 (4.053) 196 (4.143) 0.24604 0.1266 0.2376
Total Protein (g/L) 46.45 (0.745) 47 (0.83) 0.00512 0.0007 0.6248
Results of Wilcoxon signed-rank test (WSRT), paired t-test and unpaired t-test statistical analyses with significant differences (P = <0.05) indicated in
bold; ‘*’ indicates that statistical analysis was not carried out due to insufficient paired sample numbers; ‘–’ indicates that statistical analysis was not
carried out as the analyte was undetectable in all samples.
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Table 5 Effect of storage of plasma at 4 °C (n = 20) or room temperature (RT) (b = 20) for 72 h
72 h
4 °C (SE) 72 h (SE)
WSRT Paired t-test Unpaired t-test
Analyte P Value P Value P Value
Albumin (g/L) 14.9 (0.26) 15.2 (0.312) * 0.0828 0.4658
Albumin–Globulin (Ratio) 0.48 (0.006) 0.5 (0.009) 0.14706 0.1345 0.2048
ALP (U/L) 491 (34.4) 482 (33.5) 0.00932 0.0072 0.8556
ALT (U/L) 8.45 (1.29) 4.4 (0.694) 0.00028 0.0001 0.0087
Amylase (U/L) 847 (58.2) 849 (58.217) 0.57548 0.5113 0.9831
AST (U/L) 854 (171) 487 (94) 0.00008 0.0002 0.0688
Calcium (mmol/L) 3.19 (0.034) 3.15 (0.035) 0.01108 0.0174 0.3791
Chloride (mmol/L) 131 (0.537) 130 (0.471) 0.22628 0.2369 0.5462
Cholesterol (mmol/L) 9.9 (0.333) 9.8 (0.331) 0.08544 0.0692 0.839
Creatine Kinase (U/L) 4709 (385) 3840 (1270) 0 0.0002 0.0907
Creatinine (umol/L) 32.9 (3.27) 36.4 (3.601) 0.0002 0.0087 0.4763
GGT (U/L) 0 0 – – –
Globulin (g/L) 30.65 (0.563) 30.4 (0.564) 0.32708 0.2617 0.7555
Glucose (mmol/L) 5.16 (0.106) 4.9 (0.241) 0.5157 0.3928 0.4091
LDH (U/L) 1278 (298) 1410 (370) 0.05238 0.1275 0.782
Lipase (U/L) 0 0 – – –
Magnesium (mmol/L) 1.59 (0.0231) 1.61 (0.0232) 0.13622 0.1863 0.6075
Phosphate (mmol/L) 6.31 (0.136) 7.34 (0.259) 0.0001 0.0001 0.0012
Potassium (mmol/L) 0.79 (0.0203) 0.81 (0.0216) 0.57548 0.3299 0.5053
Sodium (mmol/L) 163 (0.524) 164 (0.411) 0.03846 0.0808 0.3579
Sodium–Potassium (Ratio) 209 (5.007) 205 (5.2601) 0.92828 0.4325 0.5729
Total Protein (g/L) 45 (0.786) 45 (0.789) * 0.7481 0.9644
Results of Wilcoxon signed-rank test (WSRT), paired t-test and unpaired t-test statistical analyses with significant differences (P = <0.05) indicated in
bold; ‘*’ indicates that statistical analysis was not carried out due to insufficient paired sample numbers; ‘–’ indicates that statistical analysis was not
carried out as the analyte was undetectable in all samples.
Table 6 Mean analyte concentrations from samples treated to control conditions (n = 20) and those subjected to two freeze–thaw
cycles (2x) (n = 20)
Analyte Control 2x
WSRT Paired t-test Unpaired t-test
P Value P Value P Value
Albumin (g/L) 15.4 (0.266) 16.15 (0.319) 0.00096 0.0001 0.0784
Albumin–Globulin (Ratio) 0.527 (0.007) 0.484 (0.006) 0.0003 0.0001 0.0001
ALP (U/L) 590 (24.09) 628 (26. 06) 0.00012 0.0001 0.288
ALT (U/L) 15.3 (1.29) 15.65 (1.34) 0.28014 0.2601 0.8522
Amylase (U/L) 1006 (56.4) 1070 (60.4) 0.00008 0.0001 0.4432
AST (U/L) 686 (50.9) 724 (57.1) 0 0.0011 0.6147
Calcium (mmol/L) 3.31 (0.02) 3.37 ( 0.03) 0.03846 0.0253 0.1095
Chloride (mmol/L) 131 (0.52) 133 (0.911) 0.00694 0.0045 0.0181
Cholesterol (mmol/L) 11.08 (0.333) 11.43 (0.353) 0.00152 0.001 0.4812
Creatine Kinase (U/L) 8713 (1213) 10437 (1517) 0.00008 0.0001 0.3805
Creatinine (umol/L) 29.9 (2.65) 31.95 (2.58) 0.00164 0.0018 0.5822
GGT (U/L) 0 0 – – –
Globulin (g/L) 29.35 (0.549) 33.4 (0.689) 0.00008 0.0001 0.0001
Glucose (mmol/L) 5.465 (0.178) 5.51 (0.169) 0.29372 0.2428 0.856
LDH (U/L) 1021 (132) 1058 (134) 0.11642 0.3134 0.8465
Lipase (U/L) 0 0 – – –
Magnesium (mmol/L) 1.71 (0.0368) 1.747 (0.0334) 0.01046 0.0106 0.4938
Phosphate (mmol/L) 6.299 (0.107) 6.568 (0.115) 0.0009 0.0002 0.0944
Potassium (mmol/L) 0.815 (0.182) 0.92 (0.186) 0.00096 0.0001 0.0003
Sodium (mmol/L) 163.19 (0.422) 165.75 (0.907) 0.01878 0.0168 0.0146
Sodium–Potassium (Ratio) 202 (4.645) 181 (3.28) 0.001 0.0003 0.0008
Total Protein (g/L) 44 (0.489) 49 (0.966) 0.0002 0.0001 0.0001
Results of Wilcoxon signed-rank test (WSRT), paired t-test and unpaired t-test statistical analyses with significant differences (P = <0.05) indicated in
bold; ‘–’ indicates that statistical analysis was not carried out as the analyte was undetectable in all samples.
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were employed to test significance at varying levels
of sensitivity allowing assessment of treatment
effects on biochemical results. Wilcoxon signed-
rank test which is the most sensitive of these
could identify small but significant treatment
effects. Significance solely from this test indicates
that while treatment may be having an effect on
the given analyte, it is small and may not be sig-
nificant when all paired results are compared, that
is the population of results. This significance is
given by paired t-test analysis, with such results
indicating that the treatment effects may alter an
analytes concentration significantly at a population
level. In the analytes where standard error of the
mean was high, tests for such analytes required
larger changes compared to WSRT to indicate sig-
nificance this was evident, for example, in CK
which showed high individual variation in all
investigations. To establish whether any treatment
effects cause a different clinical decision or intro-
duce significant change between differently treated
samples, the results were also treated as unrelated
to simulate the comparison of two independent
population results, and tested by unpaired t-tests.
Investigations were designed to provide infor-
mation on sample type effects (serum v plasma)
and also on various pre-analytical treatment effects
on the specimens. There was little difference in
clinical biochemistry results between serum and
plasma. It is apparent that the optimal specimen
Table 7 Mean analyte concentrations from samples treated to control conditions (n = 20) and those subjected to four freeze–thaw
cycles (4x) (n = 20)
Analyte Control (SE) 4x (SE)
WSRT Paired t-test Unpaired t-test
P Value P Value P Value
Albumin (g/L) 15.45 (0.235) 16.45 (0.246) 0.00044 0.0001 0.0001
Albumin–Globulin (Ratio) 0.53 (0.006) 0.49 (0.006) 0.00014 0.0001 0.0001
ALP (U/L) 592 (19.47) 639.95 (24.25) 0.00168 0.0015 0.1314
ALT (U/L) 13.8 (1.033) 11.9 (0.849) 0.0003 0.0001 0.1746
Amylase (U/L) 1069 (49.7) 1148 (48.1) 0.001 0.0011 0.2443
AST (U/L) 654 (64.74) 699 (70) 0.00452 0.0019 0.6393
Calcium (mmol/L) 3.3 (0.024) 3.44 (0.063) 0.08544 0.0478 0.0562
Chloride (mmol/L) 131 (0.339) 136 (2.2) 0.05 0.0319 0.038
Cholesterol (mmol/L) 11.03 (0.248) 11.57 (0.334) 0.01878 0.0171 0.2029
Creatine Kinase (U/L) 9114 (1874.1) 11199 (2269) 0.0002 0.4184 0.4264
Creatinine (umol/L) 28.4 (2.389) 31.1 (2.518) 0.01078 0.0097 0.4499
GGT (U/L) 0 0 – – –
Globulin (g/L) 29.05 (0.53) 33.75 (0.817) 0.00014 0.0001 0.0001
Glucose (mmol/L) 5.07 (0.137) 5.18 (0.165) 0.3125 0.2481 0.6114
LDH (U/L) 1396 (273.05) 1557 (325.8) 0.2113 0.1792 0.7076
Lipase (U/L) 0 0 – – –
Magnesium (mmol/L) 1.69 (0.016) 1.77 (0.04) 0.07346 0.0532 0.0856
Phosphate (mmol/L) 6.33 (0.342) 7.2 (0.253) 0.0048 0.0303 0.049
Potassium (mmol/L) 0.81 (0.0191) 0.91 (0.017) 0.00222 0.0002 0.0006
Sodium (mmol/L) 163 (0.427) 169 (2.897) 0.03846 0.0272 0.0351
Sodium–Potassium (Ratio) 203 (4.848) 188 (4.616) 0.0151 0.0086 0.0304
Total Protein (g/L) 45 (0.4651) 50 (1.043) 0.00044 0.0004 0.0003
Results of Wilcoxon signed-rank test (WSRT), paired t-test and unpaired t-test statistical analyses with significant differences (P = <0.05) indicated in
bold; ‘–’ indicates that statistical analysis was not carried out as the analyte was undetectable in all samples.
Table 8 Reference ranges of analytes from samples treated
using the standardized protocol (n = 120)
Analyte Reference Range
Albumin (g/L) 13–17
Albumin–Globulin (Ratio) 0.46–0.58
ALP (U/L) 380–821
ALT (U/L) 4.54–27.89
Amylase (U/L) 560–1534
AST (U/L) 45–1371
Calcium (mmol/L) 3–3.45
Chloride (mmol/L) 128–136
Cholesterol (mmol/L) 8.3–13.5
Creatine Kinase (U/L) 2258–20567
Creatinine (umol/L) 9.3–51
GGT (U/L) <0.01
Globulin (g/L) 25–35
Glucose (mmol/L) 4–6.2
LDH (U/L) 302–5579
Lipase (U/L) <0.01
Magnesium (mmol/L) 1.2–2
Phosphate (mmol/L) 3.5–8.5
Potassium (mmol/L) 0.665–1.023
Sodium (mmol/L) 158–170
Sodium–Potassium (Ratio) 156–238
Total Protein (g/L) 40–52
The reference ranges in bold were calculated by the 2.5–97.5 percentile
method; otherwise, they were calculated on the basis of the mean  2
SD.
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and tube type is still debated in human and vet-
erinary medicine (Humann-Ziehank & Ganter
2012). However, serum was found to have, at all
levels of significance, higher phosphate, potassium
and sodium activities. This indicates that sample
sets, as part of health monitoring, must exclusively
use one fluid type when determining electrolyte
concentrations. In the subsequent investigations,
plasma was the sample of choice so as not to
exclude fibrinogen and other coagulation cascade
proteins and also so that there would be no need
to allow time for coagulation for serum samples.
Sample treatment was found to have a much
greater effect on biochemistry results than the type
of specimen. For instance, the time elapsed from
blood collection to separation of plasma via cen-
trifugation was found to alter certain analyte activ-
ities. Alanine transaminase, calcium, chloride,
globulin, glucose, magnesium, phosphate, potas-
sium and total protein altered significantly when
72 h had elapsed before separation. Indeed,
Humann-Ziehank & Ganter (2012) advised that
in farm animals, separation of blood from farm
animals should be performed within 1 h of sam-
pling. The reasons for this included: release of CK
from cells, leakage of potassium and phosphate
from erythrocytes and effects of glycolysis. How-
ever, a sampling protocol involving a 1-h window
between time of sample collection and separation
of plasma from blood cells may be difficult to fol-
low in aquaculture. Significant differences in ana-
lyte levels between samples separated 3 h and
27 h post-sampling are less evident, but time
before separation should be minimized as in the
standardized protocol suggested in this study.
Salmon plasma, collected with the proposed stan-
dardized protocol, yielded similar ion concentrations
as reported by Bepgheim et al. (1990). Although in
their study of salmon in Norway, blood was sampled
by heart puncture, it indicates that neither the
anatomical nor geographic site of blood sampling sig-
nificantly affects the ion concentrations. Mean con-
centrations or enzyme activities in salmon serum
reported by Sandnes, Lie & Waagbo (1988) were
within the reference ranges established here (Table 8)
for all analytes apart from ALP, albumin and albu-
min–globulin ratio. In the previous study, the mean
ALP was 853 IU/L which was close to the upper
limit of the reference range (380–821 IU/L), while
the mean albumin was 20 g/L, which is not far out-
side the reference interval found here (13–17 g/L).
The albumin–globulin ratio was 0.41 in the previous
study but 0.46–0.58 in the present study. There
could be technical reasons for these differences. For
assay of enzymes such as ALP, variation in results
between laboratories can be caused by different
methodologies provided by the diagnostic kit manu-
facturers or by the temperature of the assays. Albu-
min assays could vary depending on the use of
bromocresol purple or bromocresol green as dye
binding reagent. Considering the 27 years between
the studies, geographic differences in sampling sites,
season and sea temperature of sampling days and
assay variations, there is substantial agreement
between the current and previous studies. It is consid-
ered good practice for a diagnostic laboratory to
establish reference ranges based on their own meth-
ods and instrumentation. Future work on the use of
the reference ranges is required to assess the biological
variation caused by smolt type, life stage, genetics,
feeds and site effects.
Storage temperature of samples is an important
consideration for transit of samples and after
receiving them in laboratories. However, there is
no universal recommendation of temperature and
duration of storage, although it has been shown
that many biochemical analytes are relatively
stable after 24–48 h of storage at RT (Braun et al.
2015). Our present study found that prolonged
storage at RT compared with storage at 4 °C did
affect a number of analytes including ALP, ALT,
AST, calcium, CK, creatinine and phosphate.
While this treatment caused effects by 48 h, the
effect of storage at RT became more pronounced
by 72 h. However, only ALT and phosphate levels
were altered sufficiently to be significant by
unpaired t-test. Thus, while storing samples at
room temperature has an effect on some analytes,
many remain stable for as long as 72 h. Neverthe-
less, it is recommended that storage at 4 °C is
preferable where possible.
Storage temperature in veterinary clinical bio-
chemistry can vary, though commonly, samples
for repeat analysis or long-term storage are frozen
(Reynolds et al. 2006). Previous studies have
found that the impacts of freezing are variable
depending on specific analytes in question. The
number of freeze–thaw cycles and the time elapsed
between freeze–thaw cycles have differential effects
on parameters (Thoresen et al. 1995; Braun et al.
2015). Through subjecting salmon plasma samples
to 4 °C and either 2x or 4x freeze–thaw cycles, it
was found that most analytes were sensitive to
freeze–thawing although often statistical
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significance was restricted to WRST while paired
t-test analysis indicated that such results would
not be clinically significant. Similar results have
been found by Reynolds et al. in 2006 who found
no clinically significant changes in biochemistries
after 3x freeze–thaw cycles of canine plasma.
Despite this, differences between paired salmon
plasma samples either stored at 4 °C or subject to
freezing were more pronounced after 4x freeze–
thaw cycles for albumin, globulin, phosphate,
potassium, sodium and total protein levels. These
were all significantly different, with all statistical
tests used. Cyclical freezing is widely accepted to
denature proteins (Humann-Ziehank & Ganter
2012) which would presumably reduce clinical
biochemical values due to a reduction in activity;
in this study, total protein increased after freeze–
thawing and this observation has been reported in
bovine plasma (Proverbio et al. 2015) and equine
serum (Alberghina et al. 2013). While these previ-
ous studies gave no explanation as to why this
may have been observed, it is not likely that the
freeze–thaw cycles can increase the amount of pro-
tein in plasma. It could be possible that freezing
affects the proteins in a way to increase the biuret
reaction, used to measure total protein. Perhaps a
set of peptide bonds not previously available for
the biuret reaction are exposed after thawing.
Alternatively, evaporation during this process
could cause concentration of samples.
Establishing reference intervals for analysis in
this study is valuable as little work has been car-
ried out previously in Atlantic salmon. However,
while this investigation is more extensive than pre-
vious studies, the ranges given must be used with
caution. While samples used are from two differ-
ent sites and were sampled when no diseases were
present, a clinically healthy reference interval must
also take into account as much biological variation
as possible. These were useful in investigating
effects at a clinical level, demonstrating that while
many technical pre-analytical treatments lead to
statistically significant differences, they are often
not large enough to be clinically significant being
still within the reference range for the particular
analyte. Nevertheless, delay of plasma and cell sep-
aration was found to alter magnesium and glucose
levels, while storage at room temperature reduced
ALT concentrations out with reference range mak-
ing them clinically relevant findings.
This study has highlighted that clinical bio-
chemistry parameters are sensitive to a number of
different treatments, which must be considered in
the future if blood sampling is to increase in use
during disease screening in salmon. However, the
significance of these pre-analytical treatments is
variable depending on the statistics or criteria
used. While there have been few previous investi-
gations of clinical biochemical changes during dis-
ease in salmon, it can be a pivotal aid for the
aquaculture industry in adapting a more proactive
and welfare conscious approach to health monitor-
ing. Previous studies have highlighted the poten-
tial use of individual biochemical analysis. For
example, lipase activity has been shown to be a
marker of pathological damage caused by pancreas
disease (Grant, Brown & Laider 1994; McCoy
et al. 1994). However, McCoy et al. (1994)
showed that basal plasma concentrations were neg-
ligible in most individuals which would explain
the lack of lipase activity in any samples from this
study. It is proposed that the case here is similar
for GGT where the activity was too low for the
sensitivity of the test in circulating plasma of
healthy salmon. Investigations in diseased salmon
may show, as for lipase, that this increases during
pathological damage. Therefore, future work must
assess the biomarker potential of many of these
clinical biochemistry parameters in Atlantic sal-
mon, which are well established in other areas of
veterinary and human medicine. This study has
shown that pre-analytical treatments vary in their
effects on biochemical analytes. Furthermore, it
has also shown that establishing a standardized
system for sample collection and processing would
be advantageous for widespread aquaculture health
monitoring. Such a system would prevent false
diagnosis of health status and also limit analytical
variability between and within populations.
Conclusion
Clinical biochemistry is an established and valu-
able methodology for health monitoring in live-
stock and domestic animals. However, such an
approach has not been widespread in aquaculture.
Therefore, this study has aimed to propose a stan-
dardized sampling protocol while investigating the
effects of pre-analytical treatment of specimens to
inform best practice in the future. It has high-
lighted how differential treatment can lead to vari-
ation in a number of analytes, thus making it
essential for standardized monitoring to be
adopted. Future work must aim to establish the
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effects of biological pre-analytical causes for varia-
tion, such as diet, stress and site effects. Moreover,
it has highlighted the profound effect that post-
analytical interpretation has on what we see as
being ‘significant’ treatment effects. In addition,
investigations in the changes in biochemical ana-
lytes during diseases and other treatments are
required to truly establish the diagnostic potential
of this approach. This would complement initia-
tives to discover specific biomarkers, as well as to
develop tools for assessing efficacy of treatments,
vaccines and protective/functional feeds which are
widespread within the industry.
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